Multiple Myeloma – Sagar Lonial, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 12, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Sagar Lonial, MD, Professor and Chair, Hematology & Medical Oncology, Chief Medical Officer, Winship Cancer Institute of Emory University, discuss ALCYONE, GRIFFIN, and maintenance therapy (TOURMALINE-MM3), and other multiple myeloma clinical studies presented at the American Society of Hematology 2018 meeting

Featured Videos

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents

Kristin Higgins, MD, offers opinion on the PACIFIC study in non-small cell lung cancer

Shirish Madhav Gadgeel, MBBS, on treating patients who have already received PD-L1 targeting agents